News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive OfficerNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News The OpenHW Foundation unveils the first industry-ready RISC-V ecosystem to advance European digital sovereignty News Ynvisible Announces Collaboration with Leading Automotive Manufacturer to Develop New E-Paper Product News Zynova Tech Launches the Title Industry’s First Automated Workshare Platform for Compliant, Multi-Jurisdictional Order Flow News Joveo Introduces Workday Design Approved Integration for its AI Job Advertising Platform News Live Ventures Company Engineers Autonomous, AI-Driven Distribution Network with 10x Throughput Gains News Masar Destination Achieves LEED for Communities Gold Certification
